Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

7.0K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
7.0K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

1.6K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.6K
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport01:23

Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport

2.6K
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
2.6K
The Significance of Membrane Transport01:44

The Significance of Membrane Transport

45.1K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
45.1K
Nonlinear Pharmacokinetics: Role of Transporters01:27

Nonlinear Pharmacokinetics: Role of Transporters

384
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
384
Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

2.3K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.

Cell reports·2026
Same author

Sex-Specific Differences in Amino Acids and Neurotransmitters in Multiple Sclerosis Patients Compared to Non-Neuroinflammatory Controls: A Retrospective Case-Control Study.

Neurochemical research·2026
Same author

Correction to "Exploring Simple Drug Scaffolds from the GDB Chemical Space Reveals a Chiral Bicyclic Azepane with Potent Neuropharmacology".

Journal of medicinal chemistry·2026
Same author

Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.

Cell reports·2026
Same author

Illuminating chromaffin granules: compartmentalization of endocannabinoids in bovine adrenal glands supports role in hormone modulation.

Biochemical pharmacology·2026
Same author

Targeting the endocannabinoid-eicosanoid axis to treat pain: Promise and pitfalls.

Cell chemical biology·2026

Related Experiment Video

Updated: Apr 15, 2026

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
14:25

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans

Published on: September 21, 2019

7.8K

Endocannabinoid transport revisited.

Simon Nicolussi1, Jürg Gertsch1

  • 1Institute of Biochemistry and Molecular Medicine, NCCR TransCure, University of Bern, Bern, Switzerland.

Vitamins and Hormones
|March 31, 2015
PubMed
Summary

Endocannabinoid transport across cell membranes remains unclear. This review proposes a facilitated anandamide (AEA) transport model, highlighting the need for specific probes to identify transport targets.

Keywords:
2-AGAnandamideEndocannabinoid systemEndocannabinoid uptake and transportEndocannabinoid uptake inhibitorFAAHMembrane transporter

More Related Videos

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

9.3K
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

741

Related Experiment Videos

Last Updated: Apr 15, 2026

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
14:25

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans

Published on: September 21, 2019

7.8K
Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

9.3K
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

741

Area of Science:

  • Biochemistry
  • Cell Biology
  • Neuroscience

Background:

  • Endocannabinoids, like anandamide (AEA), are crucial endogenous lipids regulating the endocannabinoid system.
  • While biosynthesis and metabolism are understood, cellular membrane transport mechanisms for endocannabinoids are largely unknown.

Purpose of the Study:

  • To critically review existing models of endocannabinoid trafficking, focusing on AEA cellular uptake.
  • To analyze the limitations and confusions arising from the lack of specificity in current AEA transport inhibitors.
  • To propose a novel model for AEA membrane transport based on a comprehensive literature analysis.

Main Methods:

  • Critical review and analysis of existing scientific literature on endocannabinoid transport.
  • Evaluation of studies utilizing various AEA transport inhibitors.
  • Comparative summary of AEA uptake inhibitors and their associated research.

Main Results:

  • Existing knowledge on AEA transport is largely derived from studies using non-specific inhibitors, leading to confusion.
  • A comparative summary of key AEA uptake inhibitors and their research applications is provided.
  • A model of facilitated AEA membrane transport, followed by intracellular shuttling and sequestration, is proposed.

Conclusions:

  • Facilitated transport is proposed as the mechanism for AEA membrane crossing.
  • Novel, highly specific molecular probes are essential for identifying the precise molecular targets involved in endocannabinoid transport.
  • Further research is needed to elucidate the complete pathway of endocannabinoid membrane transport.